RF
ASND icon

Roxbury Financial’s Ascendis Pharma A/S ASND Stock Holding History

Roxbury Financial’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42
Closed -$9.61K – 412
2026
Q1 		$9.61K Hold
42
– – 0.01% 304
2025
Q4 		$8.96K Hold
42
– – 0.01% 302
2025
Q3 		$8.35K Hold
42
– – 0.01% 296
2025
Q2 		$7.25K Buy
42
+32
+320% +$5.21K 0.01% 297
2025
Q1 		$1.57K Buy
+10
New +$1.43K ﹤0.01% 328

Other funds holding ASND

AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HJIM
Henry James International Management New York $334M AUM 49.44% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return